3D Systems Corp (DDD) 28.93 $DDD Will 3D Printing be the

New Post Public Reply Private Reply Replies (0) Message Board

Mar 4, 2015 at 6:06 PM

3D Systems Corp (DDD) 28.93 $DDD

Will 3D Printing be the Key to Speedy Amazon Delivery? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 6 mins ago
Amazon (AMZN) has a new plan to speed up delivery times - a ground fleet of delivery trucks equipped with 3-D printers.
AMZN: 382.72 (-1.89), DDD: 28.93 (-0.32), SSYS: 61.87 (+0.11), HPQ: 34.19 (-0.38)

3D Systems Corporation Earnings Deep-Dive: Is It Time To Buy?
Steve Heller, The Motley Fool - Motley Fool - Wed Mar 04, 6:52AM CST
3D Systems released its fourth-quarter and 2014 full-year earnings last Thursday, which showed a business that remains challenged to execute well across all of its segments. Consequently, a big question for long-term-focused investors may be...
DDD: 28.93 (-0.32)

3D Systems-Henry Schein Pen Deal to Sell 3D Dental Products - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 2:00PM CST
In order to strengthen its distribution network, 3D Systems Corporation (DDD) penned a multi-national distribution deal with Henry Schein, Inc.
DDD: 28.93 (-0.32), EXAR: 10.96 (+0.06), HSIC: 140.87 (+0.10), AAPL: 128.54 (-0.82)

Here's A List Of The Most Heavily Shorted Stocks In The Russell 1,000
Bespoke Investment Group - Seeking Alpha - Mon Mar 02, 11:04PM CST
Below is a basic list of the most heavily shorted stocks (short interest as a percentage of equity float) in the Russell 1,000 (large cap stocks). Each stock on this list has at least 20% of its floated shares sold short. For each stock, we also...
HLF: 31.45 (+0.21), TSLA: 202.43 (+2.87), DNOW: 23.26 (+1.05), OCN: 9.05 (-0.20), UPL: 16.75 (+0.16), SHLD: 38.86 (+0.74), CVC: 18.97 (-0.20), DO: 30.43 (+0.10), SCTY: 50.05 (-0.21), ANF: 20.27 (-3.72), NSM: 26.58 (-0.37), SSYS: 61.87 (+0.11), PPC: 28.03 (-0.58), X: 23.24 (+0.57), ZU: 13.47 (-0.40), IPGP: 97.35 (-0.64), Z: 112.96 (+1.29), GPRO: 43.01 (+2.71), MYGN: 34.30 (+0.38), GME: 40.03 (+1.35), DDD: 28.93 (-0.32), KN: 19.54 (+0.39), CLF: 6.72 (unch), ADT: 38.34 (-0.49), ATHN: 123.87 (-2.83), BTU: 6.76 (-0.47), AMD: 3.05 (-0.09), SGEN: 35.12 (-0.03), SUNE: 22.40 (-0.34), JCP: 7.88 (unch), ICPT: 266.49 (+19.13), FSL: 40.36 (-0.14), EPE: 10.37 (-0.18), OAS: 14.33 (+0.49)

3D Systems Expands Services with New Distributor Tie-Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 4:51PM CST
Leading digital design and fabrication solutions provider 3D Systems Corporation (DDD) has recently collaborated with Impression Solutions, Inc., a pioneer national distributor of imaging technology and office equipment.
AMKR: 9.67 (-0.15), DDD: 28.93 (-0.32), EXAR: 10.96 (+0.06), MLNX: 47.00 (+0.70)

Stratasys Worth the Risk as Sales Show Signs of 3D Life
at The Street - Mon Mar 02, 1:18PM CST
Stratasys is now positioning itself as a 3-D printing leader.
DDD: 28.93 (-0.32), SSYS: 61.87 (+0.11)

3D Systems (DDD) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Mon Mar 02, 11:23AM CST
The following 3D Systems (DDD) conference call took place on February 26, 2015, 08:30 AM ET. This is a transcript of that earnings call:
DDD: 28.93 (-0.32)

Stratasys +3.3% after revenue beat; 3D Systems +2%
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 8:44AM CST

DDD: 28.93 (-0.32), SSYS: 61.87 (+0.11), HSIC: 140.87 (+0.10)

Schein picks up 3D Systems' printers for dental lab customers
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 8:32AM CST

DDD: 28.93 (-0.32), HSIC: 140.87 (+0.10)

3D Systems and Henry Schein Enter Multi-National Distribution Agreement
GlobeNewswire - Mon Mar 02, 8:00AM CST
3D Systems (NYSE

DD) announced today it has entered into a multi-national distribution agreement with Henry Schein, Inc. (Nasdaq:HSIC), the world's largest provider of healthcare products and services to office-based dental, animal health and medical practitioners. Under the new agreement, Henry Schein will offer 3DS' dental 3D printers to its dental laboratory customers in the United States, Canada, France, Germany, Australia and Thailand. The agreement substantially expands 3DS' dental labs reach and integrates its printers into Henry Schein's complete digital dental solution.
DDD: 28.93 (-0.32), HSIC: 140.87 (+0.10)

Why Wall Street Played Whack-A-Mole With 3D Systems Corporation's Valuation
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 02, 7:59AM CST
Source: 3D Systems, Facebook. What: Shares of 3D printing specialist 3D Systems jumped $0.41, or better than 1%, on Friday to close at $30.47, despite three price target cuts from Wall Street firms following the Thursday-night release of its...
DDD: 28.93 (-0.32)

3D Systems: Pay More Attention To This Rather Than Earnings
Stone Fox Capital - at Seeking Alpha - Fri Feb 27, 2:35PM CST

DDD: 28.93 (-0.32), HPQ: 34.19 (-0.38)

3D Systems Needs To Do Better
Bill Maurer - at Seeking Alpha - Fri Feb 27, 2:30PM CST

DDD: 28.93 (-0.32)

Autodesk: Healthy Q4, FY16 Guidance Offers Upside
AtonRa Partners - at Seeking Alpha - Fri Feb 27, 10:43AM CST

DDD: 28.93 (-0.32), ADSK: 62.52 (-0.18)

Lessons From A Dozen Years Of Short Selling
Whitney Tilson - Seeking Alpha - Fri Feb 27, 9:39AM CST
(Editor's Note: Long-time contributor Whitney Tilson developed a presentation titled "Lessons from a Dozen Years of Short Selling" that he's presented at a handful of investment conferences in New York City. With his permission, we're now...
MBI: 9.37 (+0.09), FCEL: 1.28 (unch), HLF: 31.45 (+0.21), AFC: 25.46 (-0.02), VJET: 8.20 (-0.38), LL: 35.64 (-5.14), BLDP: 2.27 (-0.06), NSR: 22.25 (-2.88), TXTR: 26.30 (+0.11), RPTP: 10.30 (+0.69), LNKD: 265.23 (-0.31), ONVO: 5.87 (+0.07), XONE: 14.23 (-0.45), ARNA: 4.32 (+0.28), AGM: 31.67 (-0.65), PLUG: 2.93 (-0.09), FB: 80.89 (+1.29), DDD: 28.93 (-0.32), DECK: 74.40 (-0.50), TRIP: 89.24 (-1.23), CSLT: 7.49 (+0.08), LRN: 17.30 (+0.02), PCLN: 1,225.67 (-16.36), NFLX: 469.77 (-4.94), CROX: 11.52 (+0.22), CALL: 8.19 (+0.16), WRLD: 81.27 (+0.31), SODA: 18.43 (+0.17)

3D Systems Misses on Q4 Earnings, Revenues Lag (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 8:00AM CST
3D Systems (DDD) reported disappointing fourth-quarter and full-year 2014 results, continuing its recent trend of missing estimates. Adjusted earnings for the quarter came in at 13 cents per share, lagging the Zacks Consensus Estimate of 20 cents.
DDD: 28.93 (-0.32), FORM: 9.42 (unch), CRUS: 31.30 (+0.44), EXAR: 10.96 (+0.06)

3D Systems expects sales hike
at Investor's Business Daily - Thu Feb 26, 5:32PM CST
The 3D printing system maker said Q4 EPS minus 1-time items rose 10.5% to 21 cents, missing by 3 cents amid higher spending to support expansion. Revenue grew 21% to $187.4 mil, below the consensus of $202 mil, and the 4th straight quarter of...
DDD: 28.93 (-0.32)

3D Systems' (DDD) CEO Avi Reichental on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 2:10PM CST

DDD: 28.93 (-0.32)

3D Systems' Shares, Post-Earnings, Still Look Too Risky
at The Street - Thu Feb 26, 1:25PM CST
Hewlett-Packard's possible entry into 3-D printing looms as a threat.
DDD: 28.93 (-0.32), SSYS: 61.87 (+0.11), HPQ: 34.19 (-0.38)

3D Systems: No Goodwill Impairment Despite Weak Results
Illuminati Investments - at Seeking Alpha - Thu Feb 26, 11:59AM CST

DDD: 28.93 (-0.32)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....